PRA Group buys portfolios of nonperforming consumer loans from banks and other creditors, then works with borrowers to collect and resolve the debt. It is one of the larger global specialists in this asset class, with operations spanning the Americas, Europe and Australia. By recycling capital back to originators and managing charged-off accounts at scale, it sits at the intersection of credit markets and consumer debt recovery rather than traditional lending.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 272 | — | 3.7 | 3.6% |
| Q2 2025 | 290.7 | — | 42.4 | 99.4% |
| Q3 2025 | 314.1 | — | -407.7 | -2,183.8% |
| Q4 2025 | 336.4 | — | 56.5 | 205.1% |
| Q1 2026 | 317.4 | 16.7% | 28.2 | 671% |
| Q2 2026 | 375.5 | 29.1% | 57.9 | 36.7% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: BridgeBio Oncology Therapeutics, Inc. (BBOT), Bright Minds Biosciences Inc. (DRUG), Shattuck Labs, Inc. (STTK), Paysign, Inc. (PAYS), Community West Bancshares (CWBC), Ironwood Pharmaceuticals, Inc. (IRWD)